Search Results - "Rudenko, Nadiya M."

  • Showing 1 - 9 results of 9
Refine Results
  1. 1

    MicroRNAs and Oxidative Stress Markers as Additional Diagnostic Criteria for Coronary Heart Disease by Marchenko, Oksana Yu, Rudenko, Nadiya M., Krasnienkov, Dmytro S.

    “…The aim. To examine the significance of microribonucleic acids (miRNAs) and oxidative stress markers in predicting the onset of atherosclerosis and the…”
    Get full text
    Journal Article
  2. 2

    Comparative Analysis of Early Postoperative Period in Patients with Total Arterial Revascularization and Conventional Coronary Artery Bypass Grafting by Rudenko, Nadiya M., Pukas, Oleksandr Yu

    “…The use of total arterial myocardial revascularization in patients with multivessel lesions of the coronary arteries has a number of advantages, namely the…”
    Get full text
    Journal Article
  3. 3

    Algorithm for Diagnosis of Patients with Ischemic Heart Disease Depending on the Presence of Significant Coronary Artery Lesions by Marushko, Yevhen Yu, Rudenko, Nadiya M., Dzhun, Yana Yu

    “…The aim. To analyze the structure of ischemic heart disease and the prevalence of myocardial ischemia with no ob-structive coronary arteries among patients who…”
    Get full text
    Journal Article
  4. 4

    Left Ventricular Global Function Index and Myocardial Contraction Fraction on 2D Echocardiography as Integral Parameters in Patients with Coronary Artery Disease by Marchenko, Oksana Yu, Rudenko, Nadiya M., Kavalerchyk, Vladyslav

    “…Patients with coronary artery disease (CAD) form a large group among all patients with cardiovascular diseases. Atherosclerosis, as one of the main…”
    Get full text
    Journal Article
  5. 5

    Clinical Prognosis in Patients with Heart Failure and Reduced Left Ventricular Ejection Fraction after Myocardial Revascularization on the Background of Taking SGLT2 Inhibitors by Kucheriava, Mariia V., Mankovsky, George B., Rudenko, Nadiya M.

    “…The aim. To evaluate clinical and prognostic effects of sodium-glucose co-transporter 2 (SGLT2) inhibitors on primary (progression of heart failure,…”
    Get full text
    Journal Article
  6. 6

    NT-proBNP as an Additional Marker of Significant Coronary Atherosclerotic Lesions by Marchenko, Oksana Yu, Rudenko, Nadiya M., Dzhun, Yana Yu

    “…Coronary artery disease (CAD) is the leading cause for morbidity and mortality both in Ukraine and in the world, so the relevance of this problem for the…”
    Get full text
    Journal Article
  7. 7

    The Clinical Effect of Dapagliflozin in Patients with Angiographically Confirmed Coronary Artery Disease and Concomitant Type 2 Diabetes Mellitus by Dzhun, Yana Yu, Marushko, Yevhen Yu, Saienko, Yanina A., Rudenko, Nadiya M., Mankovsky, Borys M.

    “…Nowadays treatment of patients with coronary artery disease (CAD) and concomitant type 2 diabetes mellitus (DM) needs further study. The aim. Evaluation of the…”
    Get full text
    Journal Article
  8. 8

    The Impact of Chronic Heart Failure Treatment on Glycemic Variability in Patients without Diabetes Mellitus by Mankovsky, Georgiy B., Marushko, Yevhen Yu, Saienko, Yanina A., Zubovych, Ivanna V., Dzhun, Yana Yu, Monashnenko, Olha O., Rudenko, Nadiya M., Mankovsky, Borys M.

    “…Background. According to statistics, about 26 million people worldwide suffer from heart failure (HF). Currently, sodium-glucose cotransporter 2 inhibitors are…”
    Get full text
    Journal Article
  9. 9

    Use of Continuous Glucose Monitoring in Patient with Coronary Artery Disease and Type 2 Diabetes Mellitus: Case Report by Mankovsky, Georgy B., Dzhun, Yana Yu, Marushko, Yevhen Yu, Saienko, Yanina A., Rudenko, Nadiya M., Mankovsky, Boris M.

    “…We present a clinical case of continuous monitoring in a patient with coronary artery disease and concomitant type 2 diabetes mellitus. A 75-year-old patient…”
    Get full text
    Journal Article